Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Gene Synthesis, Genome Engineering), Application(Tissue Regeneration, Biofuel, Consumer Care, Food & Agriculture, Environmental) and Region (2022 - 2026)
[377 Pages Report] The global synthetic biology market size is projected to reach USD 30.7 billion by 2026 from USD 9.5 billion in 2021, at a CAGR of 26.5% during the forecast period. Major factors driving the market growth are increasing applications of synthetic biology, focus on growth initiatives and increased R&D funding in synthetic biology. Furthermore dwindling cost of DNA sequencing and synthesizing is impelling the market growth. However, biosafety, biosecurity, and ethical matters related to synthetic biology is likely to hinder the market growth in coming years.
To know about the assumptions considered for the study, Request for Free Sample Report
COVID-19 impact on the synthetic biology market
Many established pharmaceutical and biopharmaceutical companies, along with players of the market, have stepped forward to contribute to worldwide research efforts by providing synthetic biology for developing test kits, treatments, and vaccines to target the infection caused by the coronavirus. Synthetic biology is highlighted as one of the emerging technologies in a report from the European Parliament. It can fight the COVID-19 pandemic. The National Institute of Health in the US has also identified synthetic biology as one way to speed up vaccine development. Synthetic biology technologies have the potential to transform the development and production of vaccines, therapeutics, and diagnostics by utilizing their engineering approaches built on a variety of information (genomic sequences, sequence annotations, enzyme properties, metabolic models, lab protocols, algorithms, and scientific knowledge). For example, DNA- and mRNA-based vaccine technologies can ease the development and production of vaccines. These vaccines consist of synthetic nucleotide strands that trigger the formation of proteins via the individuals own cells, thereby inducing an immune response. The availability of viral sequence data can thus be rapidly translated into vaccine candidates. This has enabled ventures such as Moderna and Inovio to rapidly move into clinical development.
Global Synthetic Biology Market Dynamics
DRIVER: Increased research and development funding for synthetic biology research
According to Business Wire publication in September 2020, the R&D spending on the life sciences industry increased by 22% from 2018 to 2019. Increased in the research and development funding for pharmaceutical companys has increased in order to develop new treatments. In order to progress pharmaceutically and increase international competitiveness government has taken initiatives to fund various pharma and biotech companies. Due to this, R&D expenditure and funding have witnessed a steady increase over the years. Pharmaceutical and biotechnology companies invest strongly in research to develop breakthrough molecules to cater to the growing needs of the healthcare industry and combat new diseases. The global pharmaceutical R&D sector accounts for more than 80% of the overall R&D expenditure in the life sciences industry.
RESTRAINT: Ethical and biosafety concerns is likely to hamper the growth curve of the market
The major biosafety concern in synthetic biology is the intentional or unintentional release of synthetic organisms into the environment during research and other purposes. When synthetic microbes, released into the environment, can mutate or interact with other organisms which might result in crossbreeding with natural organisms and creating bio errors. These consequences can be threating to the ecosystem of natural organisms. Furthermore formation of antibiotic-resistant superbugs is a major biosafety concern. In contemporary years, the European Union (EU) has funded several research efforts on the environmental impact of deliberately released genetically engineered microbes for plant growth or bioremediation. These factors might hamper the growth of the market in coming years.
OPPORTUNITY: Demand for fuel alternatives
With the increasing fuel consumption and growing concerns over energy security, biofuels are achieving significant importance. Globally over 150 billion tons of biomass is generated annually. Presently, edible commodities such as maize, sugarcane, and vegetable oil are being used to produce biofuels. This is subsequently paving the way for the application of synthetic biology techniques in the development of renewable energy.
In 2020, the oligonucleotides & synthetic DNA segment led the synthetic biology market
Based on tool, the market is broadly segmented into oligonucleotides & synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms, and xeno-nucleic acids. oligonucleotides & synthetic DNA accounted for the largest share of market in 2020. The dominance of the segment is attributable to factors such as escalating demand for synthetic DNA, synthetic RNA, and synthetic genes for various applications.
The medical applications segment is projected to grow at the greatest CAGR during the forecast period.
On the basis of application, the synthetic biology market is segmented into medical applications, industrial applications, food & agriculture, and environmental applications. The medical applications segment is likely to register the significant CAGR during the forecast period. Extensive research on new and better treatments, coupled with the availability of huge private and public funding for the discovery of novel therapies, are some of the major factors augmented the growth of the segment.
North America dominated synthetic biology market in 2020.
Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2020, North America accounted for the largest share in market, followed by Europe and the Asia Pacific. The dominance is attributed to various factors such as the increase in the number of well-established synthetic biology companies and research institutes in the US and Canada. Huge ongoing research studies and growth of the overall healthcare sector are additional factors expected to impact the growth of this market. Substantial R&D spending is one of the key factors contributing to the increasing demand for synthetic biology tools and technologies among academic & research institutes and healthcare companies in North America.
Key Market Players
Key players in the synthetic biology market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies (US), Novozymes (Denmark), Ginkgo Bioworks (US), Amyris (US), Precigen, Inc. (US), GenScript (China), Twist Bioscience (US), Synthetic Genomics (US), Codexis (US), Synthego (US), Creative Enzymes (US), and Eurofins Scientific (Luxembourg).
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market size available for years |
20192026 |
|
Base year considered |
2020 |
|
Forecast period |
20212026 |
|
Forecast units |
Value (USD Billion) |
|
Segments covered |
Tool, Technology, Application, and Region |
|
Geographies covered |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
|
Companies covered |
Thermo Fisher Scientific (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Novozymes A/S (Denmark), Ginkgo Bioworks (US), Amyris (US), Precigen (US), GenScript Biotech Corporation (China), Twist Bioscience (US), Synthetic Genomics (US), Codexis (US), Synthego (US), Creative Enzymes (US), Eurofins Scientific (Luxembourg), Cyrus Biotechnology (US), ATUM (US), TeselaGen (US), Arzeda (US), Integrated DNA Technologies (US), New England Biolabs (US), Royal DSM (Netherlands), OriGene Technologies (US), Genomatica (US), Illumina (US), and Scarab Genomics (US). |
This report categorizes the synthetic biology market into the following segments and subsegments:
Synthetic Biology Market, by Tool
- Oligonucleotides and Synthetic DNA
- Enzymes
- Cloning Technologies Kits
- Synthetic Cells
- Chassis Organisms
- Xeno-nucleic Acids
Synthetic Biology Market, by Technology
- Gene Synthesis
- Genome Engineering
- Sequencing
- Bioinformatics
- Site-directed Mutagenesis
- Cloning
- Measurement and Modeling
- Microfluidics
- Nanotechnology
Synthetic Biology Market, by Application
- Medical Application
- Pharmaceuticals
- Drug Discovery and Therapeutics
- Cancer Detection & Diagnostics
- Other Drug Discovery and Therapeutic Applications
- Artificial Tissue and Tissue Regeneration
- Bio-synthesis
- Stem Cell Regulation
- Other Tissue and Tissue Regeneration Applications
- Industrial Applications
- Biofuel and Renewable Energy
- Biomaterials and Green Chemicals
- Industrial Enzymes, by Application
- Textile Industry
- Paper Industry
- Consumer Care Industry
- Skin Care & Cosmetics
- Other Consumer Care Products
- Other Industries
- Food & Agriculture
- Environmental Applications
- Bioremediation
- Biosensing
Recent Developments
- In January 2021, Novozymes launched Frontia GlutenEx. It would help wheat processors increase their gluten protein recovery and, at the same time, cut down on energy consumption.
- In February 2021, Merck partnered with BioNTech (Germany) to supply lipids for the production of Pfizer-BioNTech COVID-19 Vaccine (BNT162b2).
- In January 2021, Merck acquired AmpTec (Germany). With this acquisition, the company strengthened its product portfolio to develop and manufacture mRNA for utilizing vaccines, treatments, and diagnostics.
Frequently Asked Questions (FAQ):
What is the impact of COVID-19 on the synthetic biology market?
With broad applications of synthetic biology technologies in the development of diagnostics and treatments for the COVID-19 virus and increased research initiatives by private and government organizations, the overall synthetic biology market has shown a positive growth impact during this pandemic. With the current second wave and changing strains of the virus, it is predictable that the market would further grow in the near future.
Who are the key players in the synthetic biology market?
Key players in the synthetic biology market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Novozymes A/S (Denmark), Ginkgo Bioworks (US), Amyris (US), Precigen, Inc. (US), GenScript (China), Twist Bioscience (US), Synthetic Genomics (US), Codexis (US), Synthego (US), Creative Enzymes (US), and Eurofins Scientific (Luxembourg).
Which tools segment dominates in the synthetic biology market?
The oligonucleotides & synthetic DNA segment accounted for the largest share of the global synthetic biology market in 2020. This segment's large share can be attributed to factors such as rising demand for synthetic DNA, synthetic RNA, and synthetic genes, which are used in a wide range of applications.
Which applications segment of the global synthetic biology market is expected to witness the highest growth?
Medical applications segment is expected to witness the highest growth. The high growth rate in this segment can be attributed to the factors such as the extensive research on new and better treatments, coupled with the availability of huge private and public funding for the discovery of novel therapies.
What is the market for Synthetic Biology?
The global synthetic biology market size is projected to reach USD 30.7 billion by 2026 from USD 9.5 billion in 2021, at a CAGR of 26.5% during the forecast period. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 53)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 MARKETS COVERED
1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 LIMITATIONS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 57)
2.1 RESEARCH APPROACH
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH
FIGURE 2 PRIMARY SOURCES
FIGURE 3 SYNTHETIC BIOLOGY MARKET: BREAKDOWN OF PRIMARIES
2.1.2.1 Key industry insights
2.2 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 REVENUE SHARE ANALYSIS, 2020
FIGURE 5 AVERAGE MARKET SIZE ESTIMATION, 2020
FIGURE 6 SYNTHETIC BIOLOGY MARKET: CAGR PROJECTIONS, 20212026
FIGURE 7 SYNTHETIC BIOLOGY MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.5 RISK ANALYSIS
3 EXECUTIVE SUMMARY (Page No. - 68)
FIGURE 9 SYNTHETIC BIOLOGY MARKET, BY TOOL, 2021 VS. 2026 (USD MILLION)
FIGURE 10 MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
FIGURE 11 MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 12 GEOGRAPHIC ANALYSIS: SYNTHETIC BIOLOGY MARKET
4 PREMIUM INSIGHTS (Page No. - 71)
4.1 SYNTHETIC BIOLOGY MARKET OVERVIEW
FIGURE 13 WIDE RANGE OF APPLICATIONS OF SYNTHETIC BIOLOGY DRIVES THE MARKET GROWTH
4.2 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION & COUNTRY (2020)
FIGURE 14 MEDICAL APPLICATIONS SEGMENT AND US ACCOUNTED FOR LARGE SHARES OF THE NORTH AMERICAN MARKET IN 2020
4.3 SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020
FIGURE 15 MEDICAL APPLICATIONS SEGMENT DOMINATED THE MARKET IN 2020
4.4 SYNTHETIC BIOLOGY MARKET: REGIONAL SNAPSHOT
FIGURE 16 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 74)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 SYNTHETIC BIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 1 MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Wide range of applications of synthetic biology
5.2.1.2 Rising R&D funding and growing initiatives in synthetic biology
FIGURE 18 R&D SPENDING OF PHRMA MEMBER COMPANIES, 20052019 (USD BILLION)
5.2.1.3 Declining cost of DNA sequencing and synthesizing
FIGURE 19 REDUCTION IN COST PER RAW MEGABASE OF DNA SEQUENCING (USD) (20102020)
5.2.1.4 Increasing investments in the market
5.2.2 RESTRAINTS
5.2.2.1 Biosafety, biosecurity, and ethical concerns
5.2.3 OPPORTUNITIES
5.2.3.1 Rise in the need for fuel alternatives
5.2.3.2 Increase in the demand for protein therapeutics and personalized medicines
5.2.3.3 Growth in research on synthetic drugs and vaccines
5.2.4 CHALLENGES
5.2.4.1 Standardization of biological parts
5.3 IMPACT OF COVID-19 ON THE SYNTHETIC BIOLOGY MARKET
5.4 TECHNOLOGY ANALYSIS
TABLE 2 COMPARISON OF MODERN GENE EDITING TOOLS
5.5 ECOSYSTEM ANALYSIS
FIGURE 20 ECOSYSTEM ANALYSIS: SYNTHETIC BIOLOGY MARKET
TABLE 3 SUPPLY CHAIN ECOSYSTEM
5.6 PATENT ANALYSIS
FIGURE 21 PATENT APPLICATIONS FOR SYNTHETIC BIOLOGY, JANUARY 2010 DECEMBER 2020
5.7 PRICING ANALYSIS
TABLE 4 AVERAGE SELLING PRICE OF SYNTHETIC BIOLOGY PRODUCTS, (2020)
5.8 PORTERS FIVE FORCES ANALYSIS
TABLE 5 SYNTHETIC BIOLOGY MARKET: PORTERS FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
5.9 VALUE CHAIN ANALYSIS
FIGURE 22 VALUE CHAIN ANALYSIS OF THE SYNTHETIC BIOLOGY MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE
5.1 REGULATORY ANALYSIS
5.10.1 REGULATIONS FOR PRODUCTS DEVELOPED USING SYNTHETIC BIOLOGY TECHNIQUES
TABLE 6 REGULATIONS FOR PRODUCTS DEVELOPED USING SYNTHETIC BIOLOGY TECHNIQUES
6 SYNTHETIC BIOLOGY MARKET, BY TOOL (Page No. - 92)
6.1 INTRODUCTION
TABLE 7 MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 8 MARKET FOR TOOLS, BY REGION, 20192026 (USD MILLION)
TABLE 9 NORTH AMERICA: MARKET FOR TOOLS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 10 EUROPE: MARKET FOR TOOLS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 11 ASIA PACIFIC: MARKET FOR TOOLS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 12 LATIN AMERICA: MARKET FOR TOOLS, BY COUNTRY/REGION, 20192026 (USD MILLION)
6.2 OLIGONUCLEOTIDES & SYNTHETIC DNA
6.2.1 OLIGONUCLEOTIDES & SYNTHETIC DNA TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
TABLE 13 OLIGONUCLEOTIDES & SYNTHETIC DNA: MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 14 NORTH AMERICA: MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 20192026 (USD MILLION)
TABLE 15 EUROPE: MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 16 ASIA PACIFIC: MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 17 LATIN AMERICA: MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY/REGION, 20192026 (USD MILLION)
6.3 ENZYMES
6.3.1 DEVELOPMENT OF ENZYMES HELPED EVOLVE NEW THERAPIES FOR A RANGE OF DISEASES
TABLE 18 ENZYMES: MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 19 NORTH AMERICA: MARKET FOR ENZYMES, BY COUNTRY, 20192026 (USD MILLION)
TABLE 20 EUROPE: MARKET FOR ENZYMES, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 21 ASIA PACIFIC: MARKET FOR ENZYMES, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 22 LATIN AMERICA: MARKET FOR ENZYMES, BY COUNTRY/REGION, 20192026 (USD MILLION)
6.4 CLONING TECHNOLOGY KITS
6.4.1 NEED FOR THE CREATION OF ARTIFICIAL DNA AND ASSEMBLY DRIVING THE GROWTH OF THE SEGMENT
TABLE 23 CLONING TECHNOLOGY KITS: MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 24 NORTH AMERICA: MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 25 EUROPE: MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 26 ASIA PACIFIC: MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 27 LATIN AMERICA: MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY/REGION, 20192026 (USD MILLION)
6.5 SYNTHETIC CELLS
6.5.1 SYNTHETIC CELLS TO ALLOW TAILORING BIOLOGICS TO INCREASE ADOPTION IN THE COMING YEARS
TABLE 28 SYNTHETIC CELLS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 29 NORTH AMERICA: MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 30 EUROPE: MARKET FOR SYNTHETIC CELLS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 31 ASIA PACIFIC: MARKET FOR SYNTHETIC CELLS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 32 LATIN AMERICA: MARKET FOR SYNTHETIC CELLS, BY COUNTRY/REGION, 20192026 (USD MILLION)
6.6 CHASSIS ORGANISMS
6.6.1 INCREASING DEMAND FOR FOSSIL FUELS TO PROPEL THE DEMAND FOR CHASSIS ORGANISMS
TABLE 33 CHASSIS ORGANISMS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 34 NORTH AMERICA: MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 35 EUROPE: MARKET FOR CHASSIS ORGANISMS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 36 ASIA PACIFIC: MARKET FOR CHASSIS ORGANISMS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 37 LATIN AMERICA: MARKET FOR CHASSIS ORGANISMS, BY COUNTRY/REGION, 20192026 (USD MILLION)
6.7 XENO-NUCLEIC ACIDS
6.7.1 XENO-NUCLEIC ACIDS BEING INCREASINGLY RESEARCHED DUE TO THE GROWING DEMAND FOR BREAKTHROUGH MEDICINES
TABLE 38 XENO-NUCLEIC ACIDS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 39 NORTH AMERICA: MARKET FOR XENO-NUCLEIC ACIDS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 40 EUROPE: MARKET FOR XENO-NUCLEIC ACIDS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 41 ASIA PACIFIC: MARKET FOR XENO-NUCLEIC ACIDS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 42 LATIN AMERICA: MARKET FOR XENO-NUCLEIC ACIDS, BY COUNTRY/REGION, 20192026 (USD MILLION)
7 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY (Page No. - 111)
7.1 INTRODUCTION
TABLE 43 MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 44 MARKET FOR TECHNOLOGY, BY REGION, 20192026 (USD MILLION)
TABLE 45 NORTH AMERICA: MARKET FOR TECHNOLOGY, BY COUNTRY, 20192026 (USD MILLION)
TABLE 46 EUROPE: MARKET FOR TECHNOLOGY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 47 ASIA PACIFIC: MARKET FOR TECHNOLOGY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 48 LATIN AMERICA: MARKET FOR TECHNOLOGY, BY COUNTRY/REGION, 20192026 (USD MILLION)
7.2 GENE SYNTHESIS
7.2.1 GENE SYNTHESIS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
TABLE 49 GENE SYNTHESIS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 50 NORTH AMERICA: MARKET FOR GENE SYNTHESIS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 51 EUROPE: MARKET FOR GENE SYNTHESIS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 52 ASIA PACIFIC: MARKET FOR GENE SYNTHESIS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 53 LATIN AMERICA: MARKET FOR GENE SYNTHESIS, BY COUNTRY/REGION, 20192026 (USD MILLION)
7.3 GENOME ENGINEERING
7.3.1 INCREASING DEMAND FOR SYNTHETIC DNA AND GENES TO DRIVE THE MARKET GROWTH
TABLE 54 GENOME ENGINEERING: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 55 NORTH AMERICA: MARKET FOR GENOME ENGINEERING, BY COUNTRY, 20192026 (USD MILLION)
TABLE 56 EUROPE: MARKET FOR GENOME ENGINEERING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 57 ASIA PACIFIC: MARKET FOR GENOME ENGINEERING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 58 LATIN AMERICA: MARKET FOR GENOME ENGINEERING, BY COUNTRY/REGION, 20192026 (USD MILLION)
7.4 SEQUENCING
7.4.1 NGS TECHNOLOGY RAPIDLY BECOMING AN INDISPENSABLE AND UNIVERSAL TOOL FOR BIOLOGICAL RESEARCH
TABLE 59 SEQUENCING: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 60 NORTH AMERICA: MARKET FOR SEQUENCING, BY COUNTRY, 20192026 (USD MILLION)
TABLE 61 EUROPE: MARKET FOR SEQUENCING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 62 ASIA PACIFIC: MARKET FOR SEQUENCING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 63 LATIN AMERICA: MARKET FOR SEQUENCING, BY COUNTRY/REGION, 20192026 (USD MILLION)
7.5 BIOINFORMATICS
7.5.1 INCREASING USE OF BIOINFORMATICS TECHNOLOGY DUE TO THE RISING NEED FOR DATA MANAGEMENT AND CURATION
TABLE 64 BIOINFORMATICS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 65 NORTH AMERICA: MARKET FOR BIOINFORMATICS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 66 EUROPE: MARKET FOR BIOINFORMATICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 67 ASIA PACIFIC: MARKET FOR BIOINFORMATICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 68 LATIN AMERICA: MARKET FOR BIOINFORMATICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
7.6 CLONING
7.6.1 CLONING AIDS IN BUILDING NEW GENETIC MODULES/PATHWAYS ENABLING RAPID ADVANCES IN RESEARCH ACROSS INDUSTRIES
TABLE 69 CLONING: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 70 NORTH AMERICA: MARKET FOR CLONING, BY COUNTRY, 20192026 (USD MILLION)
TABLE 71 EUROPE: MARKET FOR CLONING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 72 ASIA PACIFIC: MARKET FOR CLONING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 73 LATIN AMERICA: MARKET FOR CLONING, BY COUNTRY/REGION, 20192026 (USD MILLION)
7.7 SITE-DIRECTED MUTAGENESIS
7.7.1 WIDE APPLICATIONS IN GENETIC ENGINEERING, DNA ASSEMBLY, AND CLONING TECHNOLOGIES DRIVING THE SEGMENT GROWTH
TABLE 74 SITE-DIRECTED MUTAGENESIS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 75 NORTH AMERICA: MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 76 EUROPE: MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 77 ASIA PACIFIC: MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 78 LATIN AMERICA: MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY/REGION, 20192026 (USD MILLION)
7.8 MEASUREMENT & MODELING
7.8.1 COMPUTATIONAL MODELING TO AID THE GROWTH OF THE SEGMENT DURING THE FORECAST PERIOD
TABLE 79 MEASUREMENT & MODELING: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 80 NORTH AMERICA: MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 20192026 (USD MILLION)
TABLE 81 EUROPE: MARKET FOR MEASUREMENT & MODELING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 82 ASIA PACIFIC: MARKET FOR MEASUREMENT & MODELING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 83 LATIN AMERICA: MARKET FOR MEASUREMENT & MODELING, BY COUNTRY/REGION, 20192026 (USD MILLION)
7.9 MICROFLUIDICS
7.9.1 DROPLET MICROFLUIDICS GAINING WIDE RECOGNITION IN THE FIELD OF SYNTHETIC BIOLOGY
TABLE 84 MICROFLUIDICS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 85 NORTH AMERICA: MARKET FOR MICROFLUIDICS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 86 EUROPE: MARKET FOR MICROFLUIDICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 87 ASIA PACIFIC: MARKET FOR MICROFLUIDICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 88 LATIN AMERICA: MARKET FOR MICROFLUIDICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
7.1 NANOTECHNOLOGY
7.10.1 CONVERGENCE BETWEEN SYNTHETIC BIOLOGY AND NANOTECHNOLOGY AIDS IN BUILDING COMPLEX BODIES
TABLE 89 NANOTECHNOLOGY: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 90 NORTH AMERICA: MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 20192026 (USD MILLION)
TABLE 91 EUROPE: MARKET FOR NANOTECHNOLOGY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 92 ASIA PACIFIC: MARKET FOR NANOTECHNOLOGY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 93 LATIN AMERICA: MARKET FOR NANOTECHNOLOGY, BY COUNTRY/REGION, 20192026 (USD MILLION)
8 SYNTHETIC BIOLOGY MARKET, BY APPLICATION (Page No. - 137)
8.1 INTRODUCTION
TABLE 94 MARKET, BY APPLICATION, 20192026 (USD MILLION)
8.2 MEDICAL APPLICATIONS
TABLE 95 MEDICAL APPLICATIONS: MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 96 MEDICAL APPLICATIONS: MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 97 NORTH AMERICA: MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 98 EUROPE: MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 99 ASIA PACIFIC: MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 100 LATIN AMERICA: MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.2.1 PHARMACEUTICALS
8.2.1.1 Potential of synthetic biology techniques in the development and manufacturing of APIs and small molecules drives the growth of the segment
TABLE 101 PHARMACEUTICALS: MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 102 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 103 EUROPE: MARKET FOR PHARMACEUTICALS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 104 ASIA PACIFIC: MARKET FOR PHARMACEUTICALS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 105 LATIN AMERICA: MARKET FOR PHARMACEUTICALS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.2.2 DRUG DISCOVERY AND THERAPEUTICS
TABLE 106 DRUG DISCOVERY AND THERAPEUTICS: MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 107 DRUG DISCOVERY AND THERAPEUTICS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 108 NORTH AMERICA: MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 109 EUROPE: MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 110 ASIA PACIFIC: MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 111 LATIN AMERICA: MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.2.2.1 Cancer detection & diagnostics
8.2.2.1.1 Increasing investments in cancer research to drive the growth of the segment
TABLE 112 SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY REGION, 20192026 (USD MILLION)
TABLE 113 NORTH AMERICA: MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 114 EUROPE: MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 115 ASIA PACIFIC: MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 116 LATIN AMERICA: MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.2.2.2 Other drug discovery and therapeutic applications
TABLE 117 SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY REGION, 20192026 (USD MILLION)
TABLE 118 NORTH AMERICA: MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 119 EUROPE: MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY/REGION,20192026 (USD MILLION)
TABLE 120 ASIA PACIFIC: MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 121 LATIN AMERICA: MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.2.3 ARTIFICIAL TISSUE & TISSUE REGENERATION
TABLE 122 ARTIFICIAL TISSUE & TISSUE REGENERATION: SYNTHETIC BIOLOGY MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 123 ARTIFICIAL TISSUE & TISSUE REGENERATION: MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 124 NORTH AMERICA: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 20192026 (USD MILLION)
TABLE 125 EUROPE: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 126 ASIA PACIFIC: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 127 LATIN AMERICA: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.2.3.1 Bio-synthesis
8.2.3.1.1 Bio-synthesis dominating the market with its increasing adoption for creating artificial genomes
TABLE 128 SYNTHETIC BIOLOGY MARKET FOR BIO-SYNTHESIS, BY REGION, 20192026 (USD MILLION)
TABLE 129 NORTH AMERICA: MARKET FOR BIO-SYNTHESIS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 130 EUROPE: MARKET FOR BIO-SYNTHESIS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 131 ASIA PACIFIC: MARKET FOR BIO-SYNTHESIS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 132 LATIN AMERICA: MARKET FOR BIO-SYNTHESIS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.2.3.2 Stem cell regulation
8.2.3.2.1 Use of synthetic biology in stem cell regeneration and reprogramming somatic cells to drive the market growth
TABLE 133 SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY REGION, 20192026 (USD MILLION)
TABLE 134 NORTH AMERICA: MARKET FOR STEM CELL REGULATION, BY COUNTRY, 20192026 (USD MILLION)
TABLE 135 EUROPE: MARKET FOR STEM CELL REGULATION, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 136 ASIA PACIFIC: MARKET FOR STEM CELL REGULATION, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 137 LATIN AMERICA: MARKET FOR STEM CELL REGULATION, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.2.3.3 Other artificial tissue and tissue regeneration applications
TABLE 138 SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY REGION, 20192026 (USD MILLION)
TABLE 139 NORTH AMERICA: MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 140 EUROPE: MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 141 ASIA PACIFIC: MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 142 LATIN AMERICA: MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3 INDUSTRIAL APPLICATIONS
TABLE 143 INDUSTRIAL APPLICATIONS: SYNTHETIC BIOLOGY MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 144 INDUSTRIAL APPLICATIONS: MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 145 NORTH AMERICA: MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 146 EUROPE: MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 147 ASIA PACIFIC: MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 148 LATIN AMERICA: MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3.1 BIOFUEL AND RENEWABLE ENERGY
8.3.1.1 Advantages of using genetically engineered organisms for the synthetic production of biofuels driving the market growth
TABLE 149 SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY REGION, 20192026 (USD MILLION)
TABLE 150 NORTH AMERICA: MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY, 20192026 (USD MILLION)
TABLE 151 EUROPE: MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 152 ASIA PACIFIC: MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 153 LATIN AMERICA: MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3.2 INDUSTRIAL ENZYMES
TABLE 154 INDUSTRIAL ENZYMES: SYNTHETIC BIOLOGY MARKET, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 155 INDUSTRIAL ENZYMES: MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 156 NORTH AMERICA: MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 20192026 (USD MILLION)
TABLE 157 EUROPE: MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 158 ASIA PACIFIC: MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 159 LATIN AMERICA: MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3.2.1 Textile industry
8.3.2.1.1 Synthetic biology to replace traditional raw materials in the textile industry
TABLE 160 SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY REGION, 20192026 (USD MILLION)
TABLE 161 NORTH AMERICA: MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 20192026 (USD MILLION)
TABLE 162 EUROPE: MARKET FOR TEXTILE INDUSTRY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 163 ASIA PACIFIC: MARKET FOR TEXTILE INDUSTRY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 164 LATIN AMERICA: MARKET FOR TEXTILE INDUSTRY, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3.2.2 Paper industry
8.3.2.2.1 Increasing use of enzymes in the pulp and paper industry
TABLE 165 SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY REGION, 20192026 (USD MILLION)
TABLE 166 NORTH AMERICA: MARKET FOR PAPER INDUSTRY, BY COUNTRY, 20192026 (USD MILLION)
TABLE 167 EUROPE: MARKET FOR PAPER INDUSTRY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 168 ASIA PACIFIC: MARKET FOR PAPER INDUSTRY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 169 LATIN AMERICA: MARKET FOR PAPER INDUSTRY, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3.2.3 Consumer care industry
TABLE 170 CONSUMER CARE INDUSTRY: SYNTHETIC BIOLOGY MARKET BY TYPE, 20192026 (USD MILLION)
TABLE 171 CONSUMER CARE INDUSTRY: MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 172 NORTH AMERICA: MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 20192026 (USD MILLION)
TABLE 173 EUROPE: MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 174 ASIA PACIFIC: MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 175 LATIN AMERICA: MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3.2.3.1 Skincare & cosmetics
8.3.2.3.1.1 Enzymes in skincare cosmetics protect skin from harmful external agents causing the breakdown of collagen
TABLE 176 SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY REGION, 20192026 (USD MILLION)
TABLE 177 NORTH AMERICA: MARKET FOR SKIN CARE & COSMETICS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 178 EUROPE: MARKET FOR SKIN CARE & COSMETICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 179 ASIA PACIFIC: MARKET FOR SKIN CARE & COSMETICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 180 LATIN AMERICA: MARKET FOR SKIN CARE & COSMETICS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3.2.3.2 Other consumer care products
TABLE 181 SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY REGION, 20192026 (USD MILLION)
TABLE 182 NORTH AMERICA: MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 183 EUROPE: MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 184 ASIA PACIFIC: MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 185 LATIN AMERICA: MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3.2.4 Other industries
TABLE 186 SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY REGION, 20192026 (USD MILLION)
TABLE 187 NORTH AMERICA: MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 20192026 (USD MILLION)
TABLE 188 EUROPE: MARKET FOR OTHER INDUSTRIES, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 189 ASIA PACIFIC: MARKET FOR OTHER INDUSTRIES, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 190 LATIN AMERICA: MARKET FOR OTHER INDUSTRIES, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.3.3 BIOMATERIALS & GREEN CHEMICALS
8.3.3.1 Use of synthetic biology for preparing silk-based proteins
TABLE 191 BIOMATERIALS AND GREEN CHEMICALS: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 192 NORTH AMERICA: MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 193 EUROPE: MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 194 ASIA PACIFIC: MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 195 LATIN AMERICA: MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.4 FOOD & AGRICULTURE
8.4.1 SYNTHETIC BIOLOGY TECHNIQUES PRODUCE METABOLITES, HEALTH PRODUCTS, AND PROCESSING AIDS IN THE FOOD AND AGRICULTURE INDUSTRY
TABLE 196 FOOD AND AGRICULTURE: SYNTHETIC BIOLOGY MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 197 NORTH AMERICA: MARKET FOR FOOD AND AGRICULTURE, BY COUNTRY, 20192026 (USD MILLION)
TABLE 198 EUROPE: MARKET FOR FOOD AND AGRICULTURE, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 199 ASIA PACIFIC: MARKET FOR FOOD AND AGRICULTURE, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 200 LATIN AMERICA: MARKET FOR FOOD AND AGRICULTURE, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.5 ENVIRONMENTAL APPLICATIONS
TABLE 201 ENVIRONMENTAL APPLICATIONS: SYNTHETIC BIOLOGY MARKET, BY TYPE, 20192026 (USD MILLION)
TABLE 202 ENVIRONMENTAL APPLICATIONS: MARKET, BY REGION, 20192026 (USD MILLION)
TABLE 203 NORTH AMERICA: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 20192026 (USD MILLION)
TABLE 204 EUROPE: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 205 ASIA PACIFIC: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 206 LATIN AMERICA: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.5.1 BIOREMEDIATION
8.5.1.1 Bioremediation helps in cleaning oil spills, preventing chemical pollution, and plugging nuclear leakages
TABLE 207 SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY REGION, 20192026 (USD MILLION)
TABLE 208 NORTH AMERICA: MARKET FOR BIOREMEDIATION, BY COUNTRY, 20192026 (USD MILLION)
TABLE 209 EUROPE: MARKET FOR BIOREMEDIATION, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 210 ASIA PACIFIC: MARKET FOR BIOREMEDIATION, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 211 LATIN AMERICA: MARKET FOR BIOREMEDIATION, BY COUNTRY/REGION, 20192026 (USD MILLION)
8.5.2 BIOSENSING
8.5.2.1 Biosensors utilize microalgae due to high reproductive rates and ease of culturing
TABLE 212 SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY REGION, 20192026 (USD MILLION)
TABLE 213 NORTH AMERICA: MARKET FOR BIOSENSING, BY COUNTRY, 20192026 (USD MILLION)
TABLE 214 EUROPE: MARKET FOR BIOSENSING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 215 ASIA PACIFIC: MARKET FOR BIOSENSING, BY COUNTRY/REGION, 20192026 (USD MILLION)
TABLE 216 LATIN AMERICA: MARKET FOR BIOSENSING, BY COUNTRY/REGION, 20192026 (USD MILLION)
9 SYNTHETIC BIOLOGY MARKET, BY REGION (Page No. - 193)
9.1 INTRODUCTION
TABLE 217 , BY REGION, 20192026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 23 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET SNAPSHOT
TABLE 218 NORTH AMERICA: MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 219 NORTH AMERICA: MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 220 NORTH AMERICA: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 221 NORTH AMERICA: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 222 NORTH AMERICA: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 223 NORTH AMERICA: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 224 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 225 NORTH AMERICA: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 226 NORTH AMERICA: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 227 NORTH AMERICA: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 228 NORTH AMERICA: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.2.1 US
9.2.1.1 The US to dominate the North American synthetic biology market
TABLE 229 US: MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 230 US: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 231 US: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 232 US: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 233 US: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 234 US: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 235 US: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 236 US: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 237 US: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 238 US: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Strong research infrastructure and availability of funding to support market growth
TABLE 239 CANADA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 240 CANADA: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 241 CANADA: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 242 CANADA: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 243 CANADA: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 244 CANADA: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 245 CANADA: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 246 CANADA: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 247 CANADA: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 248 CANADA: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.3 EUROPE
TABLE 249 EUROPE: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 250 EUROPE: MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 251 EUROPE: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 252 EUROPE: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 253 EUROPE: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 254 EUROPE: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 255 EUROPE: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 256 EUROPE: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 257 EUROPE: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 258 EUROPE: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 259 EUROPE: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 The rapidly growing pharmaceutical market to drive the market growth
TABLE 260 GERMANY: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 261 GERMANY: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 262 GERMANY: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 263 GERMANY: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 264 GERMANY: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 265 GERMANY: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 266 GERMANY: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 267 GERMANY: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 268 GERMANY: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 269 GERMANY: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.3.2 UK
9.3.2.1 The UK to hold the largest share of the European market
TABLE 270 UK: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 271 UK: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 272 UK: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 273 UK: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 274 UK: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 275 UK: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 276 UK: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 277 UK: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 278 UK: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 279 UK: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Research across all industries to be strongly supported by the government
TABLE 280 FRANCE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 281 FRANCE: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 282 FRANCE: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 283 FRANCE: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 284 FRANCE: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 285 FRANCE: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 286 FRANCE: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 287 FRANCE: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 288 FRANCE: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 289 FRANCE: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.3.4 SWITZERLAND
9.3.4.1 Market growth to be primarily driven by the well-established pharmaceutical & biotechnology industry in the country
TABLE 290 SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 291 SWITZERLAND: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 292 SWITZERLAND: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 293 SWITZERLAND: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 294 SWITZERLAND: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 295 SWITZERLAND: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 296 SWITZERLAND: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 297 SWITZERLAND: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 298 SWITZERLAND: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 299 SWITZERLAND: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.3.5 DENMARK
9.3.5.1 Denmark to have the third-largest commercial drug development pipeline in Europe
TABLE 300 DENMARK: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 301 DENMARK: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 302 DENMARK: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 303 DENMARK: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 304 DENMARK: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 305 DENMARK: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 306 DENMARK: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 307 DENMARK: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 308 DENMARK: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 309 DENMARK: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.3.6 ITALY
9.3.6.1 Growth in this market to be mainly driven by increasing life science R&D in the country, funded by both public and private organizations
TABLE 310 ITALY: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 311 ITALY: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 312 ITALY: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 313 ITALY: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 314 ITALY: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 315 ITALY: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 316 ITALY: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 317 ITALY: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 318 ITALY: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 319 ITALY: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.3.7 SPAIN
9.3.7.1 Spain to have a well-established network of research centers, universities, and hospitals, forming an ideal environment for research
TABLE 320 SPAIN: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 321 SPAIN: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 322 SPAIN: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 323 SPAIN: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 324 SPAIN: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 325 SPAIN: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 326 SPAIN: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 327 SPAIN: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 328 SPAIN: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 329 SPAIN: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.3.8 REST OF EUROPE
TABLE 330 ROE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 331 ROE: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 332 ROE: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 333 ROE: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 334 ROE: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 335 ROE: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 336 ROE: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 337 ROE: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 338 ROE: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 339 ROE: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 24 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET SNAPSHOT
TABLE 340 ASIA PACIFIC: MARKET, BY COUNTRY, 20192026 (USD MILLION)
TABLE 341 ASIA PACIFIC: MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 342 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 343 ASIA PACIFIC: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 344 ASIA PACIFIC: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 345 ASIA PACIFIC: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 346 ASIA PACIFIC: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 347 ASIA PACIFIC: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 348 ASIA PACIFIC: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 349 ASIA PACIFIC: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 350 ASIA PACIFIC: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 Growth in R&D to enhance technological capabilities in the country driving the demand for high-quality research tools
TABLE 351 CHINA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 352 CHINA: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 353 CHINA: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 354 CHINA: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 355 CHINA: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 356 CHINA: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 357 CHINA: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 358 CHINA: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 359 CHINA: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 360 CHINA: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Large number of research initiatives toward the development of precision medicine supporting the market growth
TABLE 361 JAPAN: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 362 JAPAN: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 363 JAPAN: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 364 JAPAN: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 365 JAPAN: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 366 JAPAN: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 367 JAPAN: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 368 JAPAN: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 369 JAPAN: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 370 JAPAN: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.4.3 AUSTRALIA
9.4.3.1 Increasing focus of the healthcare system on precision medicine to offer significant growth opportunities
TABLE 371 AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 372 AUSTRALIA: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 373 AUSTRALIA: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 374 AUSTRALIA: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 375 AUSTRALIA: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 376 AUSTRALIA: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 377 AUSTRALIA: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 378 AUSTRALIA: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 379 AUSTRALIA: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 380 AUSTRALIA: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Increasing pharma R&D activities and government funding for the biotechnology industry driving the market growth
TABLE 381 INDIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 382 INDIA: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 383 INDIA: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 384 INDIA: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 385 INDIA: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 386 INDIA: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 387 INDIA: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 388 INDIA: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 389 INDIA: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 390 INDIA: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 391 ROAPAC: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 392 ROAPAC: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 393 ROAPAC: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 394 ROAPAC: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 395 ROAPAC: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 396 ROAPAC: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 397 ROAPAC: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 398 ROAPAC: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 399 ROAPAC: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 400 ROAPAC: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 401 LATAM: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 402 LATAM: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 403 LATAM: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 404 LATAM: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 405 LATAM: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 406 LATAM: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 407 LATAM: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 408 LATAM: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 409 LATAM: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 410 LATAM: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Growing pharmaceutical industry to drive the market growth
TABLE 411 BRAZIL: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 412 BRAZIL: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 413 BRAZIL: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 414 BRAZIL: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 415 BRAZIL: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 416 BRAZIL: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 417 BRAZIL: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 418 BRAZIL: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 419 BRAZIL: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 420 BRAZIL: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Increasing support for biotechnology infrastructure development to drive the market growth
TABLE 421 MEXICO: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 422 MEXICO: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 423 MEXICO: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 424 MEXICO: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 425 MEXICO: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 426 MEXICO: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 427 MEXICO: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 428 MEXICO: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 429 MEXICO: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 430 MEXICO: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 431 ROLA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 432 ROLA: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 433 ROLA: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 434 ROLA: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 435 ROLA: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 436 ROLA: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 437 ROLA: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 438 ROLA: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 439 ROLA: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 440 ROLA: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
9.6 MIDDLE EAST AND AFRICA
9.6.1 INCREASING PARTNERSHIPS AMONG GLOBAL PLAYERS WITH GOVERNMENT ORGANIZATIONS IN THE REGION TO SUPPORT THE MARKET GROWTH
TABLE 441 MEA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 20192026 (USD MILLION)
TABLE 442 MEA: MARKET, BY TECHNOLOGY, 20192026 (USD MILLION)
TABLE 443 MEA: MARKET, BY APPLICATION, 20192026 (USD MILLION)
TABLE 444 MEA: MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 445 MEA: MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 20192026 (USD MILLION)
TABLE 446 MEA: MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 20192026 (USD MILLION)
TABLE 447 MEA: MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
TABLE 448 MEA: MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 20192026 (USD MILLION)
TABLE 449 MEA: MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 20192026 (USD MILLION)
TABLE 450 MEA: MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 20192026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 298)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 25 KEY PLAYER STRATEGIES IN THE SYNTHETIC BIOLOGY MARKET, 2018 2021
10.3 MARKET SHARE ANALYSIS
FIGURE 26 SYNTHETIC BIOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
10.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STAR
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE
10.5.4 EMERGING COMPANIES
FIGURE 28 SYNTHETIC BIOLOGY MARKET: COMPANY EVALUATION QUADRANT, 2020
10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 29 SYNTHETIC BIOLOGY MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
10.7 COMPANY PRODUCT FOOTPRINT
TABLE 451 PRODUCT PORTFOLIO ANALYSIS: SYNTHETIC BIOLOGY MARKET (2020)
10.8 COMPANY GEOGRAPHIC FOOTPRINT
TABLE 452 GEOGRAPHIC REVENUE MIX: SYNTHETIC BIOLOGY MARKET (2020)
10.9 COMPETITIVE SCENARIO
10.9.1 MARKET: PRODUCT LAUNCHES, JANUARY 2018 APRIL 2021
10.9.2 MARKET: DEALS, JANUARY 2018APRIL 2021
10.9.3 MARKET: OTHER DEVELOPMENTS, JANUARY 2018 APRIL 2021
11 COMPANY PROFILE (Page No. - 311)
11.1 KEY MARKET PLAYERS
(Business overview, Products offered, Recent developments, SWOT analysis, MNM view)*
11.1.1 THERMO FISHER SCIENTIFIC
FIGURE 30 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
11.1.2 NOVOZYMES
FIGURE 31 NOVOZYMES: COMPANY SNAPSHOT (2020)
11.1.3 MERCK KGAA
FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2020)
11.1.4 EUROFINS SCIENTIFIC
FIGURE 33 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2020)
11.1.5 AGILENT TECHNOLOGIES
FIGURE 34 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2020)
11.1.6 AMYRIS
FIGURE 35 AMYRIS: COMPANY SNAPSHOT (2020)
11.1.7 CODEXIS
FIGURE 36 CODEXIS: COMPANY SNAPSHOT (2020)
11.1.8 TWIST BIOSCIENCE
FIGURE 37 TWIST BIOSCIENCE: COMPANY SNAPSHOT
11.1.9 GENSCRIPT
FIGURE 38 GENSCRIPT: COMPANY SNAPSHOT (2020)
11.1.10 PRECIGEN
FIGURE 39 PRECIGEN: COMPANY SNAPSHOT (2020)
11.1.11 GINKGO BIOWORKS
11.1.12 SYNTHETIC GENOMICS (SGI)
11.2 OTHER PLAYERS
11.2.1 SYNTHEGO
11.2.2 CREATIVE ENZYMES
11.2.3 CYRUS BIOTECHNOLOGY
11.2.4 ATUM
11.2.5 TESELAGEN
11.2.6 ARZEDA
11.2.7 INTEGRATED DNA TECHNOLOGIES
11.2.8 NEW ENGLAND BIOLABS
*Business overview, Products offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 367)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the synthetic biology market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the synthetic biology market. The secondary sources used for this study include Industry Association of Synthetic Biology (IASB), International Association of Synthetic Biology, European Association of Synthetic Biology, Society for Biological Engineering (SBE), Systems and Synthetic Biology Journal, Asian Synthetic Biology Association, Synthetic Biology Engineering Research Center. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the synthetic biology market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive secondary research
- The revenues generated from the synthetic biology business of leading players have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, and forecast the global synthetic biology market based on the tool, technology, application, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, opportunities, and trends)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall synthetic biology market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the synthetic biology market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for this report:
Company Information
- An additional five company profiles
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
Growth opportunities and latent adjacency in Synthetic Biology Market
how many interviews were conducted for data validation?
Can you elaborate more on the global geographical growth scenario for the Synthetic Biology Market?
How much share does the top companies holds, of global Synthetic Biology Market?
Can you share the detailed information on key factors Driving the growth of Global Synthetic Biology Market?